Xu Xiaoming, Wang Jingzhi, Duan Qilong
Department of Gastroenterology, Jining First People's Hospital, Jining, China.
Department of Radiotherapy Oncology, The Affiliated Yancheng First Hospital of Nanjing University Medical School, The First People's Hospital of Yancheng, Yancheng, China.
Front Oncol. 2023 Mar 1;13:1083618. doi: 10.3389/fonc.2023.1083618. eCollection 2023.
Surgery is the sole curative therapy for gallbladder cancer (GBC) patients. Confronting an aging society, the demand to treat elderly patients with GBC is increasing. But there are few reports on survival benefit in elderly GBC patients treated with surgery. Therefore, we designed this population-based study to assess the survival benefit of surgery in GBC patients aged 70 years or older.
GBC patients aged 70 years or older were identified in the surveillance, epidemiology, and end results cancer (SEER) database from 2010 to 2017. A 1:1 propensity score matching (PSM) analysis was conducted to balance the baseline data of patients. Overall survival (OS) and cancer-specific survival (CSS) of patients were evaluated by Kaplan-Meier analysis and compared with log-rank test. Independent risk factors associated with OS and CSS were determined by univariate and multivariate Cox proportional hazard regression analyses and subgroup analysis were performed.
A total of 2055 GBC patients aged 70 years or older were included in our study, with 1734 patients underwent surgery. Before PSM, the age, AJCC stage, TNM stage, and chemotherapy were significantly different between the surgery and no-surgery group (all P<0.05). Patients with surgery had significantly longer OS and CSS than those without surgery (P<0.0001). After 1:1 PSM, the differences in clinicopathological characteristics were reduced (all P>0.05). Kaplan-Meier analysis also showed patients received surgery had significantly better OS and CSS (P<0.0001). Subgroup analysis further indicated that almost all subgroups received surgery had OS and CSS advantage, especially patients aged 70-84 years old. Finally, univariate and multivariate COX regression analyses showed that age, AJCC stage and T stage were independent prognostic factors for OS and CSS in patients undergoing surgery.
Our study found that surgery significantly improved OS and CSS in GBC patients aged 70-84 years, but more prospective studies are needed to prove our findings.
手术是胆囊癌(GBC)患者唯一的治愈性疗法。面对老龄化社会,治疗老年GBC患者的需求日益增加。但关于手术治疗老年GBC患者生存获益的报道较少。因此,我们开展了这项基于人群的研究,以评估手术对70岁及以上GBC患者的生存获益。
在2010年至2017年的监测、流行病学和最终结果癌症(SEER)数据库中识别出70岁及以上的GBC患者。进行1:1倾向评分匹配(PSM)分析以平衡患者的基线数据。通过Kaplan-Meier分析评估患者的总生存(OS)和癌症特异性生存(CSS),并采用对数秩检验进行比较。通过单因素和多因素Cox比例风险回归分析确定与OS和CSS相关的独立危险因素,并进行亚组分析。
我们的研究共纳入2055例70岁及以上的GBC患者,其中1734例接受了手术。在PSM之前,手术组和非手术组之间的年龄、美国癌症联合委员会(AJCC)分期、TNM分期和化疗情况存在显著差异(均P<0.05)。接受手术的患者的OS和CSS显著长于未接受手术的患者(P<0.0001)。在1:1 PSM之后,临床病理特征的差异减小(均P>0.05)。Kaplan-Meier分析还显示接受手术的患者的OS和CSS显著更好(P<0.0001)。亚组分析进一步表明,几乎所有接受手术的亚组都具有OS和CSS优势,尤其是70-84岁的患者。最后,单因素和多因素COX回归分析表明,年龄、AJCC分期和T分期是接受手术患者OS和CSS的独立预后因素。
我们的研究发现,手术显著改善了70-84岁GBC患者的OS和CSS,但需要更多的前瞻性研究来证实我们的发现。